| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/06/2011 | WO2010099515A3 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo |
| 01/06/2011 | WO2010099432A3 Recognition of cyp2e1 epitopes |
| 01/06/2011 | WO2010099219A3 Designer ligands of tgf-beta superfamily |
| 01/06/2011 | WO2010096588A3 Cell culture media containing combinations of proteins |
| 01/06/2011 | WO2010095881A3 Target activated cell/tissue translocation peptide for impermeable compound strategy, and uses thereof |
| 01/06/2011 | WO2010091651A4 Novel antimicrobial peptides |
| 01/06/2011 | WO2010090758A3 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods |
| 01/06/2011 | WO2010088691A3 Compositions and methods for treating or preventing conditions and diseases associated with mannheimia haemolytica |
| 01/06/2011 | WO2010086743A3 Codon-optimised hepatitis b virus core antigen |
| 01/06/2011 | WO2010072621A3 Process for the preparation of a peptide powder form |
| 01/06/2011 | WO2010064207A3 Selective anticancer chimeric peptide |
| 01/06/2011 | WO2009007849A3 Il-23 receptor antagonists and uses thereof |
| 01/06/2011 | US20110004965 Compositions and methods for modulation of plant cell division |
| 01/06/2011 | US20110004964 Insecticidal proteins derived from bacillus thuringiensis |
| 01/06/2011 | US20110004962 Methods of controlling plant see and organ size |
| 01/06/2011 | US20110004959 Down-regulation and silencing of allergen genes in transgenic peanut seeds |
| 01/06/2011 | US20110004952 Method for the separation of cells |
| 01/06/2011 | US20110004951 Methods and compositions for identifying compounds that inhibit hiv-1 subunit-specific reverse transcriptase |
| 01/06/2011 | US20110003976 Removal of lipopolysaccharides from protein-lipopolysaccharide complexes by non flammable solvents |
| 01/06/2011 | US20110003975 Method of denaturing whey protein |
| 01/06/2011 | US20110003974 Modified fluorescent proteins and methods for using same |
| 01/06/2011 | US20110003973 Antibodies to zalpha11 cytokine receptors |
| 01/06/2011 | US20110003971 Modulators and modulation of the interaction between rgm and neogenin |
| 01/06/2011 | US20110003970 Multi block copolymers |
| 01/06/2011 | US20110003969 Conjugation methods |
| 01/06/2011 | US20110003844 Regulation of cardiac contractility and heart failure propensity |
| 01/06/2011 | US20110003784 Opsin-binding ligands, compositions and methods of use |
| 01/06/2011 | US20110003756 C5a Receptor Antagonists |
| 01/06/2011 | US20110003755 Tumor Endothelial Marker 5-alpha Molecules and Uses Thereof |
| 01/06/2011 | US20110003754 Peptide-Conjugated Oligonucleotide Therapeutic and Method of Making and Using Same |
| 01/06/2011 | US20110003753 COMPOSITIONS AND METHODS FOR DISRUPTING THE FUNCTION OF THE TRANSCRIPTIONAL REPRESSOR COMPONENT Sin3A-PAH2 DOMAIN TO INDUCE DIFFERENTIATION AND GROWTH INHIBITION IN BREAST CANCER |
| 01/06/2011 | US20110003750 Human 3 relaxin |
| 01/06/2011 | US20110003746 Protein variants |
| 01/06/2011 | US20110003744 Glycopegylated Erythropoietin Formulations |
| 01/06/2011 | US20110003741 Novel neurturin conjugates for pharmaceutical use |
| 01/06/2011 | US20110003736 Pesticidal proteins |
| 01/06/2011 | US20110003735 Peptide derivative fusion inhibitors of hiv infection |
| 01/06/2011 | US20110003734 Proteins and polynucleotides of vibrio cholerae |
| 01/06/2011 | US20110003706 Proliferation markers in clinical practice and their use for breast cancer prognosis or diagnosis |
| 01/06/2011 | US20110003697 Plant myb transcription factor homologs |
| 01/06/2011 | US20110003385 Regulated transcription of targeted genes and other biological events |
| 01/06/2011 | US20110003379 Chimeric autoprocessing polypeptides and uses thereof |
| 01/06/2011 | US20110003362 Conjugates of biological substances |
| 01/06/2011 | US20110003340 Synthetic genes for plant gums and other hydroxyproline-rich proteins |
| 01/06/2011 | US20110003339 Pathogenic Escherichia Coli Associated Protein |
| 01/06/2011 | US20110003333 Method for Increasing Expression Yield of a Protein of Interest |
| 01/06/2011 | US20110003332 Recombinantly modified plasmin |
| 01/06/2011 | US20110003319 Transgenic Trasnchromosomal Rodents for Making Human Antibodies |
| 01/06/2011 | US20110003318 Nucleotide and protein sequence of mammastatin and methods of use |
| 01/06/2011 | US20110003314 Hapten, Immunogens and Derivatives of Ascomycin Useful for Preparation of Antibodies and Immunoassays |
| 01/06/2011 | US20110003313 Amplified labeled conjugate for use in immunoassays |
| 01/06/2011 | US20110003276 Blood separation and concentration system |
| 01/06/2011 | US20110003067 Soybean variety a1016498 |
| 01/06/2011 | US20110003066 Soy protein products having altered characteristics |
| 01/06/2011 | US20110003061 Soybean variety a1016523 |
| 01/06/2011 | US20110003060 Soybean variety a1016137 |
| 01/06/2011 | US20110003059 Soybean variety a1016124 |
| 01/06/2011 | US20110003058 Soybean variety a1016119 |
| 01/06/2011 | US20110003057 Soybean variety a1015492 |
| 01/06/2011 | US20110003056 Soybean variety a1016134 |
| 01/06/2011 | US20110003055 Soybean variety a1015993 |
| 01/06/2011 | US20110002994 Method of regulating the th17 pathway and its associated metabolic impact |
| 01/06/2011 | US20110002972 Neuroendocrine factors for treatment of degenerative diseases |
| 01/06/2011 | US20110002962 Immunogenic PcpA Polypeptides and Uses Thereof |
| 01/06/2011 | US20110002960 Influenza hemagglutinin and neuraminidase variants |
| 01/06/2011 | US20110002957 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 01/06/2011 | US20110002956 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/06/2011 | US20110002954 Rhoc-based immunotherapy |
| 01/06/2011 | US20110002951 Modified Leukotoxin Gene and Protein |
| 01/06/2011 | US20110002941 Antibodies that Specifically Bind Hedgehog-Derived Polypeptides |
| 01/06/2011 | US20110002919 Antagonists of neuropilin receptor function and use thereof |
| 01/06/2011 | US20110002916 Plasmodium falciparum antigens and their vaccine and diagnostic applications |
| 01/06/2011 | US20110002914 Hybrid tetnus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 01/06/2011 | US20110002910 Therapeutic agents comprising pro-apoptotic proteins |
| 01/06/2011 | US20110002909 Method, composition, and article of manufacture for providing alpha-1 antitrypsin |
| 01/06/2011 | US20110002894 Compositions and methods for treating and preventing heart tissue degeneration and uses thereof |
| 01/06/2011 | US20110002890 Treatment of tumors with genetically engineered herpes virus |
| 01/06/2011 | US20110002888 Albumin Fusion Proteins |
| 01/06/2011 | US20110002882 Methods of treating cancer using il-21 |
| 01/06/2011 | US20110002848 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 01/06/2011 | CA2767129A1 Compositions and methods for silencing apolipoprotein b |
| 01/06/2011 | CA2767012A1 Dermaseptin b2 used as an inhibitor of the growth of a tumor |
| 01/06/2011 | CA2766972A1 Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor |
| 01/06/2011 | CA2766899A1 Compositions and methods for diagnosing and/or treating influenza infection |
| 01/06/2011 | CA2766810A1 Terpene synthases from santalum |
| 01/06/2011 | CA2766805A1 Hyr1 as a target for active and passive immunization against candida |
| 01/06/2011 | CA2766794A1 Markers of xmrv infection and uses thereof |
| 01/06/2011 | CA2766739A1 Method for the detection of organ or tissue injury |
| 01/06/2011 | CA2766704A1 Enhanced phytase variants |
| 01/06/2011 | CA2766537A1 Multimeric peptide conjugates and uses thereof |
| 01/06/2011 | CA2766505A1 T cell receptors |
| 01/06/2011 | CA2766097A1 Expression of transcription regulators that provide heat tolerance |
| 01/06/2011 | CA2765932A1 Use of interfering rna for treating an hiv infection |
| 01/06/2011 | CA2765602A1 N-terminal truncated amyloid beta protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer's disease |
| 01/06/2011 | CA2763692A1 Neurotoxins exhibiting shortened biological activity |
| 01/05/2011 | EP2270234A1 Method for creating polynucleotide and polypeptide sequences |
| 01/05/2011 | EP2270209A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/05/2011 | EP2270188A2 Defensin polynucleotides and methods of use |
| 01/05/2011 | EP2270187A2 Defensin polynucleotides and methods of use |
| 01/05/2011 | EP2270186A2 Defensin polynucleotides and methods of use |